News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Schechter Adam H
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Schechter Adam H (Director) has filed a Form 4 on DAVITA INC.|
Txns:
| Granted 475 shares
@ $0 |
|
| 07/05/2023 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 73,013 restricted stock units
@ $0 |
|
| 05/17/2023 |
4
| Schechter Adam H (Director) has filed a Form 4 on DAVITA INC.|
Txns:
| Granted 516 shares
@ $0 |
|
| 04/03/2023 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 42,353 shares
@ $0
Paid exercise price by delivering 18,646 shares
@ $224.7, valued at
$4.2M
|
|
| 03/17/2023 |
4
| Schechter Adam H (Director) has filed a Form 4 on DAVITA INC.|
Txns:
| Granted 658 shares
@ $0 |
|
| 02/14/2023 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 1,170 shares
@ $248.13, valued at
$290.3k
Exercised 2,656 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 1,368 shares
@ $244.5, valued at
$334.5k
Exercised 3,507 restricted stock units
@ $0 |
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Schechter Adam H (Director) has filed a Form 4 on DAVITA INC.|
Txns:
| Granted 81 shares
@ $0 |
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2022 |
3
| Schechter Adam H (Director) has filed a Form 3 on DAVITA INC. |
| 02/15/2022 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 7,970 restricted stock units
@ $0
Granted 28,100 options to buy
@ $276.26, valued at
$7.8M
|
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 886 shares
@ $288.78, valued at
$255.9k
Exercised 2,007 restricted stock units
@ $0 |
|
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2020 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Paid exercise price by delivering 885 shares
@ $207.23, valued at
$183.4k
Exercised 2,006 restricted stock units
@ $0 |
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 10,520 restricted stock units
@ $0
Granted 45,600 options to buy
@ $182.51, valued at
$8.3M
|
|
| 11/05/2019 |
4
| Schechter Adam H (President & CEO) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 6,020 restricted stock units
@ $0
Granted 24,800 options to buy
@ $166.53, valued at
$4.1M
Granted 65,100 options to buy
@ $191.51, valued at
$12.5M
|
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2018 |
4
| Schechter Adam H (EVP & Pres-Global Human Health) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 132,744 shares
@ $73.9752, valued at
$9.8M
Sold 145,135 shares
@ $73.6637, valued at
$10.7M
Exercised 277,879 options to buy
@ $39.29, valued at
$10.9M
|
|
| 09/18/2018 |
4
| Schechter Adam H (EVP & Pres-Global Human Health) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 100,000 shares
@ $70.1778, valued at
$7M
Sold 7,360 shares
@ $70.1781, valued at
$516.5k
Exercised 100,000 options to buy
@ $36.56, valued at
$3.7M
|
|
| 06/19/2018 |
4
| Schechter Adam H (EVP & Pres-Global Human Health) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 100,000 shares
@ $61.0016, valued at
$6.1M
Sold 34,094 shares
@ $61.0015, valued at
$2.1M
Exercised 100,000 options to buy
@ $36.56, valued at
$3.7M
|
|
| 05/08/2018 |
4
| Schechter Adam H (EVP & Pres-Global Human Health) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 139,063 options to buy
@ $57.75, valued at
$8M
|
|
| 03/01/2018 |
4
| Schechter Adam H (EVP & Pres-Global Human Health) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 34,094 shares
@ $54.72, valued at
$1.9M
|
|
| 02/14/2018 |
4
| Schechter Adam H (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Granted 1,038 restricted stock units
@ $0 |
|
| 02/09/2018 |
4
| Schechter Adam H (Director) has filed a Form 4 on LABORATORY CORP OF AMERICA HOLDINGS|
Txns:
| Sold 1,263 shares
@ $169.29, valued at
$213.8k
Exercised 1,263 restricted stock units
@ $0 |
|
| 01/16/2018 |
4
| Schechter Adam H (EVP & Pres-Global Human Health) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Sold 50,994 shares
@ $61.63, valued at
$3.1M
Sold 50,608 shares
@ $61.63, valued at
$3.1M
Exercised 50,994 options to buy
@ $36.56, valued at
$1.9M
|
|
| 12/18/2017 |
4
| Schechter Adam H (EVP & Pres-Global Human Health) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Gifted 750 shares
@ $0 |
|
| 05/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/10/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|